Abstract
Neurofilament light chain is a promising biomarker of disease activity and treatment response in relapsing-remitting multiple sclerosis (MS). Its role in progressive MS is less clear. The aim of the study was to assess the relationship between plasma neurofilament light chain (pNfL) and disease activity as defined by the concept NEDA-3 (No Evident Disease Activity), and brain volumetry, in a cohort of patients with the progressive disease form (PMS). Levels of pNfL (SIMOA technology) were examined in 52 PMS patients and analysed in relationship to NEDA-3 status and annual brain volume loss (BVL) during the last 12 months. The statistical model was developed using logistic regression analysis, including demographic, clinical and magnetic resonance imaging (MRI) data as independent variables. Dependent variables were NEDA-3 status and BVL. The mean age of the study participants (n=52, 50% females) was 45.85 (SD, 9.82) and the median disability score was 5.0 (IQR: 5.0-5.5). ROC analysis showed that pNfL predicts NEDA-3 (the sensitivity and specificity of the model were 77.8% and 87.6%, respectively, P<0.001) and abnormal BVL (the sensitivity and specificity were 96.6% and 68.2%, respectively, P<0.001). The results show that pNfL l...Continue Reading
References
Nov 1, 1983·Neurology·J F Kurtzke
Sep 6, 2013·Annals of Neurology·Maria Pia SormaniNicola De Stefano
May 30, 2014·Neurology·Fred D LublinChris H Polman
Jan 30, 2015·Neurology·Ernst-Wilhelm RadueJeffrey A Cohen
Apr 24, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Nicola De StefanoMaria Pia Sormani
Nov 21, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Ludwig KapposDavorka Tomic
Jan 13, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Jens KuhleCristina Granziera
Apr 14, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Jens KuhleHenrik Zetterberg
May 28, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Tomas UherDana Horakova
Apr 7, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Gavin GiovannoniEva Havrdová
May 18, 2017·Annals of Neurology·Giulio DisantoUNKNOWN Swiss Multiple Sclerosis Cohort Study Group
Jul 7, 2017·Neurology. Neuroimmunology and Neuroinflammation·Marcus W KochVolker Knappertz
Aug 11, 2017·NeuroImage. Clinical·Martijn D SteenwijkHugo Vrenken
Aug 24, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Finn SellebjergJeppe Romme Christensen
Oct 29, 2017·Neurology·Lenka NovakovaJan Lycke
Dec 23, 2017·CNS Drugs·Bianca Weinstock-GuttmanUNKNOWN MS-MRIUS Study Group
Mar 16, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Nelly SillerStefan Bittner
Jun 4, 2018·Brain : a Journal of Neurology·Christian BarroJens Kuhle
Jul 20, 2018·Journal of Neuroinflammation·Irene HåkanssonJan Ernerudh
Sep 2, 2018·Nature Reviews. Neurology·Michael KhalilJens Kuhle
Feb 10, 2019·Neurology·Jens KuhleLudwig Kappos
Jul 28, 2019·Acta Neurologica Scandinavica·Diana FerraroPatrizia Sola